Ordinary Rebalance | Solactive Pharma Breakthrough Value Index | 19th September 2022
In the ordinary rebalancing the following index composition will be implemented effective open 19.09.2022:
| ABBVIE INC |
| ALNYLAM PHARMACEUTICALS INC |
| AMICUS THERAPEUTICS INC |
| BASILEA PHARMACEUTICA LTD. |
| BEIGENE LTD-ADR |
| BIOGEN INC |
| BIOMARIN PHARMACEUTICAL INC |
| BRISTOL-MYERS SQUIBB CO |
| CHUGAI PHARMACEUTICAL CO LTD ORD |
| CLINUVEL PHARMACEUTICALS LTD |
| CSL LTD ORD |
| EMERGENT BIOSOLUTIONS INC |
| GRIFOLS SA CLASS A |
| HORIZON THERAPEUTICS PLC |
| INCYTE CORP |
| IPSEN SA |
| JAZZ PHARMACEUTICALS PLC |
| NIPPON SHINYAKU CO LTD |
| NOVARTIS AG-ADR |
| PHARMA MAR SA |
| PTC THERAPEUTICS INC |
| ROCHE HOLDING AG |
| SANOFI SA |
| SEAGEN INC |
| SINO BIOPHARMACEUTICAL LTD ORD |
| SUPERNUS PHARMACEUTICALS INC |
| SWEDISH ORPHAN BIOVITRUM AB |
| TRAVERE THERAPEUTICS INC |
| ULTRAGENYX PHARMACEUTICAL INC |
| UNITED THERAPEUTICS CORP |
| VERTEX PHARMACEUTICALS INC |
| XENCOR INC |